期刊文献+

山莨菪碱联合盐酸卡替洛尔滴眼液在延缓近视发展中的作用

0.5%raceanisedamine and 2%carteolol hydrochloride eye drops for the treatment of childhood myopia
在线阅读 下载PDF
导出
摘要 目的:探讨0.5%消旋山莨菪碱滴眼液和2%盐酸卡替洛尔滴眼液治疗儿童近视的有效性。方法:患者双眼点用0.5%消旋山莨菪碱滴眼液和2%盐酸卡替洛尔滴眼液,早晚各一次。对用药前后的年近视发展度、眼轴、眼压和视力进行配对t检验,采用用药前后自身对照。定期观察近视发展情况。结果:年龄7~14岁(平均10.12±2.56岁),接受治疗时间1.0~2.5年。用药前后年近视发展度分别为(-1.05±0.53)D/年和(-0.56±0.55)D/年。用药后年近视发展度明显少于用药前(P<0.01)。用药前及用药后随诊矫正视力分别为4.83±0.12和4.94±0.23,用药后末次随诊矫正视力优于用药前(P<0.01)用药前后眼轴分别为(23.84±1.66)mm和(24.50±1.89)mm,用药后眼轴较用药前增长(P>0.05)。结论:点用山莨菪碱联合盐酸卡替洛尔滴眼液具有延缓近视发展的作用。 Objective: To evaluate the efficacy of 0.5%raceanisedamine and 2%carteolol hydrochloride eye drops for the treatment of childhood myopia.Methods:Both eyes were treated with0.5%raeeanisedamine and 2%carteolol hydrochloride eye drops twice daily tor more than a year. The patients were followed up every half year during the treatment period.A paired sample t-test was used to compare the yearly progression of myopia, axial length,intraocular pressure and visual acuity before and after treatment.Results : 60 children completed the trial.The yearly progression of myopia before and after treatment was-1.05±0.53 diopters per year and -0.56± 0.55 diopters peryear.respeetively,and after treatment progression was signifieandy slower than before treatment (P 〈0.00).The corrected visual aeuities before treatment and at the last visit were 4.83 ±0.12and 4.94±0.23.respectively,and the corrected visual acuity at the last visit was signifieanfly better than before treatment (P〈0.002).The axial lengths before and after treatment were ( 23.84±1.66 )mm and( 24.50:1:1.89 )mm.respectively, and axial length after treatment was significantly longer( P〉0.05 )Conclusion : 0.5%raeeanisedamine eye drops and 2%carteolol hydrochloride eye drops were effective in slowing the progression of myopia.
出处 《北方药学》 2013年第10期18-19,共2页 Journal of North Pharmacy
关键词 近视 山莨菪碱滴眼液 盐酸卡替洛尔滴眼液 Raceanisodamine Carteolol hydrochloride Myopia
  • 相关文献

参考文献7

二级参考文献29

  • 1胡诞宁.近视药物治疗研究进展[J].眼视光学杂志,2004,6(2):71-74. 被引量:30
  • 2宋前方,宋前流,陈幼蓓,章微微.阿托品治疗近视眼患者的视觉电生理观察[J].中国中医眼科杂志,2007,17(1):52-53. 被引量:13
  • 3胡延宁.阿托品治疗近视眼的研究[J].实用眼科杂志,1988,(6):20-20.
  • 4胡诞宁.高度近视遗传规律探讨[J].中华眼科杂志,1979,15:159-162.
  • 5Negrel AD, Thylefors B. The global impact of eye injuries[J]. Ophthalmic Epidemiol 1998 ;5 : 143-169.
  • 6Saw SM,Shil-Yen EC,Koh A,Tan D. Interventions to retard myopia progression in children: an evidence-based update [J]. Acta Ophthalmol 2002; 109(2 ) :415-421.
  • 7Lind G J, Chew S J, Marzani D. Muscarinic acetylcboline receptor antagonists inhibit chick scleral chondrocytes [ J ]. Invest Ophthalmal Vis Sci 1998 ;39 ( 12 ) :2217-2231.
  • 8Chua WH,Balakrishnan V, Chart YH. Atropine for the treatment of childhood myopia [J]. Ophthalmology 2006; 113 ( 12 ) : 2285- 2291.
  • 9Luu CD,Lau AM,Koh AH, Tan D. Multifocal electroretinogram in children on atropine treatment for myopia[J]. Br J Ophthalmol 2005 ;89(2) : 151-153.
  • 10Wu HM, Seet B, Yap EP, et al. Does education explain ethnic differences in myopia prevalence? A population -based study of young adult males ill Singapore [J]. Optom Vis Sci, 2001,78(4) : 234-239.

共引文献314

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部